ZENG QINGPING,TORO ANDRAS,PATTERSON JOHN BRUCE,WADE WARREN STANFIELD,ZUBOVICS ZOLTAN,YANG YUN,WU ZHIPENG
申请号：
IN3389/KOLNP/2012
公开号：
IN2012KN03389A
申请日:
2012.11.05
申请国别(地区):
IN
年份:
2013
代理人:
摘要：
Compounds which directly inhibit IRE-1a activity in vitro,and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1 dependent decay (RIDD) and can be used as single agents or in combination therapies.
